Top Markets
#1 DogBull DogBull +74.47%
#2 Siren Siren +31.86%
#3 OriginTrail OriginTrail +14.24%
#4 Verus Coin Verus Coin +10.66%
#5 龙虾 (Lobster) 龙虾 (Lobster) +10.08%
#6 Falcon Finance Falcon Finance +8.82%
#7 COTI COTI +7.56%
#8 PulseChain PulseChain +6.82%
#9 Tutorial Tutorial +6.20%
#10 DODO DODO +5.79%
Coin of the day
DogBull DogBull
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
HST Global, Inc. HST Global, Inc.

HST Global, Inc.

HSTC
Classificação em ações #22246
HST Global, Inc. operates as a biotechnology firm dedicated to integrated... HST Global, Inc. operates as a biotechnology firm dedicated to integrated health and wellness. The company establishes and acquires a global network of specialized wellness centers, which offer homeopathic and alternative treatments primarily for patients suffering from advanced-stage cancers. Furthermore, HST Global focuses on the development of homeopathic and alternative therapeutic candidates that are either currently undergoing or have successfully completed clinical trials. These potential treatments are designed to address late-stage cancers as well as various other critical, life-threatening conditions. The company's corporate headquarters are situated in Hampton, Virginia.
Preço da ação
$0.65
Última sincronização: 2026-08-20
Valor de mercado
$91.93M
Variação (1 dia)
0.00%
Variação (1 ano)
324,900.01%
País
US
Negociar HST Global, Inc. (HSTC)

Categoria

Healthcare
Lucros da HST Global, Inc. (HSTC)
Lucros em 2026 TTM: 0
De acordo com os últimos relatórios financeiros da HST Global, Inc., os ganhos atuais da empresa são de 0. Em 2026, a empresa teve ganhos de 0, igual a aos ganhos de 2026, que foram de 0. Os ganhos apresentados nesta página são os ganhos antes de juros e impostos, conhecidos como EBIT.
Histórico de lucros da HST Global, Inc. de 2026 a 2026
Lucros no final de cada ano
Ano Lucros Alterar
Não há dados suficientes para as datas fornecidas.
Lucros de empresas semelhantes ou concorrentes
Empresa Lucros Diferença de Lucros País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH